¼¼°èÀÇ Àü±â °æ·Ã ¿ä¹ý ½ÃÀå
Electroconvulsive Therapy
»óǰÄÚµå : 1753080
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 381 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 7,997,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 23,992,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Àü±â °æ·Ã ¿ä¹ý ¼¼°è ½ÃÀåÀº 2030³â±îÁö 1,890¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 1,690¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â Àü±â °æ·Ã ¿ä¹ý ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 1,890¸¸ ´Þ·¯¿¡ À̸£°í, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 1.9%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Unilateral Electroconvulsive TherapyÀº CAGR 1.4%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1,280¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Bilateral Electroconvulsive Therapy ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 2.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 460¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇÑÆí, Áß±¹Àº CAGR 3.4%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ Àü±â °æ·Ã ¿ä¹ý ½ÃÀåÀº 2024³â¿¡ 460¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö´Þ·¯, Áß±¹Àº CAGR 350¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 3.4%·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 0.8%¿Í 1.6%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.1%·Î ÃßÁ¤µË´Ï´Ù.

¼¼°èÀÇ Àü±â °æ·Ã ¿ä¹ý(ECT) ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Àü±â °æ·Ã ¿ä¹ýÀÌ Á¤½Å°ú Ä¡·á¿¡¼­ ´Ù½Ã ÁÖ¸ñ¹Þ´Â ÀÌÀ¯´Â?

Àü±â °æ·Ã ¿ä¹ý(ECT)Àº ÁßÁõ ¹× Ä¡·á ÀúÇ×¼º Á¤½ÅÁúȯ¿¡ ´ëÇÑ ¸Å¿ì È¿°úÀûÀÎ Ä¡·á¹ýÀ¸·Î Àü ¼¼°è Á¤½Å°ú ¿µ¿ª¿¡¼­ ´Ù½Ã ÁÖ¸ñ¹Þ°í ÀÖÀ¸¸ç, Àü½Å¸¶Ãë ÇÏ¿¡ ³ú¿¡ Á¶ÀýµÈ Àü·ù¸¦ È帣°Ô ÇÏ¿© ÀÇÇÐÀûÀ¸·Î Á¶ÀýµÈ ´Ü½Ã°£ ¹ßÀÛÀ» À¯¹ßÇÏ¿© Áõ»óÀ» ºü¸£°Ô ¿ÏÈ­½ÃŰ´Â Ä¡·á¹ýÀÔ´Ï´Ù. ƯÈ÷, ¿ì¿ïÁõ, ½ÉÇÑ ¿ì¿ïÁõÀ̳ª Á¶¿ïÁõÀ» µ¿¹ÝÇÑ ¾ç±Ø¼º Àå¾Ö, ÀϺΠÁ¤½ÅºÐ¿­Áõ, ¾à¹° Ä¡·á¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â °æ¿ì¿¡ È¿°úÀûÀÔ´Ï´Ù. °ú°Å¿¡´Â ³í¶õÀÇ ¿©Áö°¡ ÀÖ°í ³«ÀÎÂïÈù Ä¡·á¹ýÀ̾úÁö¸¸, ÇöÀç´Â °úÇÐÀû ±Ù°Å°¡ ÀÖ´Â Áõ°Å¿¡ ±â¹ÝÇÑ Ä¡·á¹ýÀ¸·Î ÀÎÁ¤¹Þ°í ÀÖ½À´Ï´Ù. ¸¶Ãë¿Í ±ÙÀÌ¿ÏÁ¦ »ç¿ë, ÃֽŠÀü±â°æ·Ã Ä¡·á±âÀÇ Á¤È®ÇÑ Åõ¿© µî ÀÇ·á ÇÁ·ÎÅäÄÝÀÇ ¹ßÀüÀ¸·Î Àü±â°æ·Ã Ä¡·áÀÇ ¾ÈÀü¼º°ú ȯÀÚ °æÇèÀº Å©°Ô °³¼±µÇ¾ú½À´Ï´Ù. ÀÓ»ó °á°ú´Â È¿°ú°¡ ³ªÅ¸³ª±â±îÁö ¸î ÁÖ¿¡¼­ ¸î ´ÞÀÌ °É¸®´Â ¾à¹° Ä¡·á¿¡ ºñÇØ Áõ»óÀÌ ´õ »¡¸® °³¼±µÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. Àü ¼¼°èÀûÀÎ ½ºÆ®·¹½º, »çȸÀû °í¸³, °æÁ¦Àû ºÒ¾ÈÁ¤¼ºÀ¸·Î ÀÎÇØ Á¤½ÅÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ´Â »óȲ¿¡¼­ ECT´Â Á¤½ÅÀÇÇÐ ÅøÅ¶À¸·Î¼­ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖÀ¸¸ç, ±âÁ¸ Ä¡·á¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â ȯÀڵ鿡°Ô Èñ¸ÁÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

ECTÀÇ ¾ÈÀü¼º, Á¤È®¼º, ¼ö¿ë¼ºÀº ±â¼ú Çõ½Å°ú ÀÓ»óÇõ½ÅÀ» ÅëÇØ ¾î¶»°Ô °³¼±µÇ°í Àִ°¡?

Çö´ëÀÇ Àü±â °æ·Ã ¿ä¹ý´Â ÀÇ·á±â¼ú°ú ½Å°æ°úÇÐÀÇ ¹ßÀüÀ¸·Î Å« ÇýÅÃÀ» ¹Þ°í ÀÖÀ¸¸ç, ÀÌ´Â º¸´Ù Ç¥ÀûÈ­µÈ ȯÀÚ Ä£È­ÀûÀÎ Ä¡·á¹ýÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ °³¼± »çÇ× Áß Çϳª´Â ´ÜÆÞ½º ¹× ÃÊ´ÜÆÞ½º ÆÄÇü ÀڱرâÀÇ °³¹ß·Î, ¿ª»çÀûÀ¸·Î ECT¿Í °ü·ÃµÈ ÀÎÁöÀû ºÎÀÛ¿ë, ƯÈ÷ ±â¾ï·Â Àå¾Ö¸¦ °¨¼Ò½ÃÄ×½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡¸¦ ÅëÇØ ÀÓ»óÀǴ ȯÀÚÀÇ ¿¬·É, Áø´Ü ¹× ³ú »ý¸®Çп¡ µû¶ó ÀÚ±Ø ¸Å°³ º¯¼ö¸¦ Á¶Á¤ÇÒ ¼ö ÀÖ¾î º¸´Ù ¸ÂÃã Ä¡·á°¡ °¡´ÉÇØÁ³½À´Ï´Ù. À̹ÌÁö À¯µµ¸¦ ÅëÇÑ Àü±Ø ¹èÄ¡¿Í ¼¼¼Ç Áß ³úÆÄ ¸ð´ÏÅ͸µÀº ºÒÇÊ¿äÇÑ Àü·ù ³ëÃâÀ» ÃÖ¼ÒÈ­Çϸ鼭 À¯¹ßµÈ ¹ßÀÛÀÌ Ä¡·áÀû È¿°ú¸¦ ¹ßÈÖÇÒ ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù. ½Ç½Ã°£ ¸ð´ÏÅ͸µ ±â¼úÀÇ »ç¿ëÀ¸·Î Á¤È®¼º°ú ¾ÈÀü¼ºÀÌ Çâ»óµÇ¾î ºÎÀÛ¿ëÀ» ÁÙÀ̸鼭 ÀϰüµÈ Ä¡·á °á°ú¸¦ ¾òÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ¸ÞÆ®Çí½ÃÅ»°ú °°Àº ´Ü½Ã°£ ÀÛ¿ë ¾à¹°°ú »è½Ã´ÒÄݸ°°ú °°Àº ±ÙÀ° ÀÌ¿ÏÁ¦ »ç¿ëÀ» Æ÷ÇÔÇÑ ÃֽЏ¶Ãë ÇÁ·ÎÅäÄÝÀº ºü¸¥ ȸº¹ ½Ã°£À¸·Î º¸´Ù ¿øÈ°ÇÑ ½Ã¼ú¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÇöÀç µ¥ÀÌÅÍ °ü¸® ½Ã½ºÅÛÀ» ÅëÇØ Ä¡·á °úÁ¤À» ÃßÀûÇϰí, ÇÁ·ÎÅäÄÝÀ» ÃÖÀûÈ­Çϰí, °á°ú¸¦ ȯÀÚ ±â·Ï¿¡ ÅëÇÕÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ECT¸¦ ½ÅºñÈ­½Ã۰í, ÀϹÝÀΰú Àü¹®°¡µéÀÇ ÀνÄÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ±× °á°ú, Á¤½Å°ú ÀÇ»ç¿Í ¿ËÈ£ ´ÜüµéÀº ECT¸¦ È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀ¸·Î ¿ËÈ£Çϰí, ³«ÀÎÀ» ÁÙÀ̰í, ÁßÁõ Á¤½ÅÁúȯ¿¡ ´ëÇÑ Á¶±â °³ÀÔÀ» ÃËÁøÇϱâ À§ÇØ ECT¸¦ ¿ËÈ£Çϰí ÀÖ½À´Ï´Ù.

¿Ö Áö¿ª ÀÇ·á Á¤Ã¥°ú ¹®È­Àû ÀνÄÀÌ ECT À̿뿡 ¿µÇâÀ» ¹ÌÄ¡´Â°¡?

Àü±â °æ·Ã ¿ä¹ýÀÇ Ã¤Åðú ½ÇÇàÀº Áö¿ª¸¶´Ù Å©°Ô ´Ù¸£¸ç, ÀÇ·á ÀÎÇÁ¶ó, ±ÔÁ¦ Á¤Ã¥, ¹®È­Àû ŵµ, Á¤½Å °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä ¼öÁØ¿¡ µû¶ó Å©°Ô ¿µÇâÀ» ¹Þ½À´Ï´Ù. ¹Ì±¹, ij³ª´Ù, ¿µ±¹, È£ÁÖ µî °í¼Òµæ ±¹°¡¿¡¼­´Â ECT°¡ ÀÔ¿ø Á¤½Å°ú º´µ¿À̳ª ¿Ü·¡ Á¤½Å°ú Áø·á¼Ò¿¡¼­ ÀϹÝÀûÀ¸·Î ½ÃÇàµÇ°í ÀÖÀ¸¸ç, ¹Ì±¹Á¤½ÅÀÇÇÐȸ(APA), ¿µ±¹¿Õ¸³Á¤½ÅÀÇÇÐȸ(Royal College of Psychiatrists)¿Í °°Àº Àü¹®±â°üÀÇ È®¸³µÈ °¡À̵å¶óÀÎÀÌ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °¡À̵å¶óÀο¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù. º¸Çè Àû¿ë, ÀÇ»ç ÈÆ·Ã, Àü¹® ½Ã¼³ÀÇ Á¸Àç·Î ÀÎÇØ À̵é Áö¿ª¿¡¼­´Â ECT¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ´õ ¾ÈÁ¤ÀûÀÔ´Ï´Ù. ¹Ý¸é, ÁßÀú¼Òµæ ±¹°¡¿¡¼­´Â Á¦ÇÑµÈ Á¤½Å°ú ÀÇ·á ÀÚ¿ø, ÈÆ·ÃµÈ Àη ºÎÁ·, ±¸½Ä Àåºñ µîÀÇ À庮¿¡ Á÷¸éÇÏ¿© ECT ¼­ºñ½ºÀÇ °¡¿ë¼º°ú ǰÁúÀÌ Á¦ÇѵǴ °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ, Á¤½ÅÁúȯ¿¡ ´ëÇÑ ¹®È­Àû Æí°ß°ú ¹Ìµð¾î¿¡¼­ ¹¦»çµÇ´Â ECT¿¡ ´ëÇÑ µÎ·Á¿òÀº ECTÀÇ ¼ö¿ë°ú ȯÀÚÀÇ µ¿ÀǸ¦ ¹æÇØÇϰí ÀÖ½À´Ï´Ù. ÀϺΠ±¹°¡¿¡¼­´Â ¹Ì¼º³âÀÚ¿¡ ´ëÇÑ ECT »ç¿ë¿¡ ¹ýÀû Á¦ÇÑÀ» µÎ°Å³ª »ç¹ýºÎÀÇ ½ÂÀÎÀ» ÇÊ¿ä·Î ÇÏ´Â ±¹°¡µµ ÀÖ¾î Ä¡·á¸¦ Áö¿¬½ÃŰ°Å³ª ¹æÇØÇϰí ÀÖ½À´Ï´Ù. µ¿ÀÇ¿Í ÀÎÁöÀû ºÎÀÛ¿ëÀ» µÑ·¯½Ñ À±¸®Àû ³íÀïµµ Á¤Ã¥°ú °üÇàÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¼¼°è Á¤½Åº¸°Ç ÀÌ´Ï¼ÅÆ¼ºê¿Í WHO°¡ Áö¿øÇÏ´Â ÇÁ·Î±×·¥Àº ÀÀ±Þ Á¤½ÅÀÇÇп¡¼­ ECTÀÇ Á߿伺À» Á¡Á¡ ´õ ÀνÄÇϰí ÇÁ·ÎÅäÄÝÀ» Ç¥ÁØÈ­Çϰí, ÀÓ»óÀǸ¦ ±³À°Çϰí, Ä¡·á¹ÞÁö ¸øÇÏ´Â Áö¿ª¿¡¼­ Á¢±Ù¼ºÀ» È®´ëÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀº ´Ù¾çÇÑ Àα¸Áý´ÜÀÇ ½É°¢ÇÑ Á¤½ÅÁúȯ¿¡ ´ëÇÑ Ä¡·á °ÝÂ÷¸¦ ÇØ¼ÒÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

¼¼°è Àü±â °æ·Ã Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

¼¼°è Àü±â °æ·Ã ¿ä¹ý ½ÃÀåÀÇ ¼ºÀå µ¿·ÂÀº Á¤½ÅÁúȯÀÇ À¯º´·ü Áõ°¡, Ä¡·á ÀúÇ×¼º ȯÀÚ±ºÀÇ È®´ë, ¾ÈÀüÇϰí È¿°úÀûÀÎ ÁßÀç·Î¼­ Àü±â °æ·Ã ¿ä¹ý¿¡ ´ëÇÑ Á¦µµÀû ÀÎ½Ä Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ¼ö¾ï ¸íÀÌ ¾Î°í ÀÖ´Â ÁÖ¿ä ¿ì¿ïÀå¾Ö´Â ECT°¡ ÀûÀÀÁõÀÌ µÇ´Â ÁÖ¿ä ÁúȯÀ̸ç, ¾à¹° Ä¡·á¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â ȯÀÚÀÇ ºñÀ²ÀÌ ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÚ»ì Ãæµ¿À̳ª Á¤½Åº´Àû Ư¡À» µ¿¹ÝÇÑ ÁßÁõ ¿ì¿ïÁõ°ú °°Àº »ý¸íÀ» À§ÇùÇÏ´Â Á¤½ÅÁúȯ¿¡ ´ëÇÑ ECTÀÇ ºü¸¥ È¿°ú¿¡ ´ëÇÑ ÀÓ»óÀÇ¿Í °¡Á·µéÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ °ø°ø ¹× ¹Î°£ ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ECTÀÇ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó, ƯÈ÷ 3Â÷ Á¤½Å°ú ÀÇ·á ½Ã¼³ÀÇ ¹ßÀüµµ ÇѸòÀ» Çϰí ÀÖÀ¸¸ç, ´õ ³ÐÀº ¹üÀ§ÀÇ Ä¡·á°¡ °¡´ÉÇØÁö°í ȯÀÚµéÀÇ Ä¡·á °á°ú°¡ °³¼±µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¹Àº ±¹°¡¿¡¼­ °í·ÉÈ­°¡ ÁøÇàµÇ°í ÀÖ°í, Èı⠿ì¿ïÁõ ¹× Ä¡¸Å¿Í °ü·ÃµÈ Á¤½Å Áõ»óÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó, Æú¸®ÆÄ¸¶½´Æ¼Äÿ¡ ºñÇØ »ó´ëÀûÀ¸·Î ¾çÈ£ÇÑ À§Çè-ÆíÀÍ ÇÁ·ÎÆÄÀÏÀ» °¡Áø ECT°¡ ¼±È£µÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú º¸Çè ±Þ¿© ¹üÀ§ÀÇ È®´ë´Â ȯÀÚµéÀÇ °æÁ¦Àû À庮À» ³·Ãß°í ÀÖÀ¸¸ç, ÇÑÆíÀ¸·Î´Â ±¹°¡ Á¤½Å °Ç°­ Àü·«¿¡ ECT°¡ Æ÷ÇÔµÈ °ÍÀº ECTÀÇ ÀÓ»óÀû Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. È¿°úÀûÀÎ Á¤½Å °Ç°­ °³ÀÔ¿¡ ´ëÇÑ Àü ¼¼°èÀûÀÎ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ECT´Â Áß¿äÇÑ Ä¡·á¹ýÀ¸·Î ¼ºÀåÇϰí ÀÖÀ¸¸ç, Çö´ëÈ­, Áõ°Å ±â¹Ý ¿ËÈ£, ±×¸®°í Àü ¼¼°è Á¤½Å °Ç°­ À§±â¸¦ ÇØ°áÇØ¾ß ÇÏ´Â ±ä±ÞÇÑ Çʿ伺ÀÇ ÇýÅÃÀ» ¹ÞÀ» Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(ÆíÃø Àü±â °æ·Ã ¿ä¹ý, ¾çÃø Àü±â °æ·Ã ¿ä¹ý);¿ëµµ(´ë¿ì¿ïÁõ¼º Àå¾Ö, Á¶¿ïÁõ, Á¤½ÅºÐ¿­Áõ, ±âŸ ¿ëµµ);ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ¹× Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 48°³»ç)

AI ÅëÇÕ

¿ì¸®´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Electroconvulsive Therapy Market to Reach US$18.9 Million by 2030

The global market for Electroconvulsive Therapy estimated at US$16.9 Million in the year 2024, is expected to reach US$18.9 Million by 2030, growing at a CAGR of 1.9% over the analysis period 2024-2030. Unilateral Electroconvulsive Therapy, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$12.8 Million by the end of the analysis period. Growth in the Bilateral Electroconvulsive Therapy segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.6 Million While China is Forecast to Grow at 3.4% CAGR

The Electroconvulsive Therapy market in the U.S. is estimated at US$4.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.5 Million by the year 2030 trailing a CAGR of 3.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 1.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.1% CAGR.

Global Electroconvulsive Therapy (ECT) Market - Key Trends & Drivers Summarized

Why Is Electroconvulsive Therapy Experiencing Renewed Attention in Psychiatric Treatment?

Electroconvulsive Therapy (ECT) is undergoing a resurgence in the global psychiatric field as a highly effective intervention for severe and treatment-resistant mental health conditions. ECT involves the application of controlled electrical currents to the brain under general anesthesia, inducing a brief, medically supervised seizure that can result in rapid symptom relief. It is particularly effective in cases of major depressive disorder, bipolar disorder with severe depression or mania, and certain forms of schizophrenia, especially when patients do not respond to pharmacological treatments. What once carried a controversial and stigmatized image is now being recognized as a scientifically supported, evidence-based treatment that is often life-saving for individuals at high risk of suicide or catatonia. Advances in medical protocols, including the use of anesthesia, muscle relaxants, and precise dosing with modern ECT machines, have significantly improved the safety and patient experience of the procedure. Clinical outcomes often show quicker symptom improvement compared to medications, which can take weeks or months to show results. Given the rising prevalence of mental health disorders globally-fueled by pandemic stress, social isolation, and economic instability-ECT is becoming increasingly critical in the psychiatric toolkit, offering hope for patients unresponsive to traditional therapies.

How Are Technological and Clinical Innovations Enhancing ECT Safety, Precision, and Acceptance?

Modern electroconvulsive therapy has benefited greatly from advancements in medical technology and neuroscience, leading to more targeted, patient-friendly procedures. One of the most significant improvements is the development of brief-pulse and ultra-brief-pulse waveform stimulators, which reduce the cognitive side effects historically associated with ECT, particularly memory disturbances. These devices allow clinicians to tailor stimulation parameters based on patient age, diagnosis, and brain physiology, enabling more personalized treatments. Image-guided electrode placement and EEG monitoring during sessions ensure that the seizure induced is therapeutic while minimizing exposure to unnecessary current. The use of real-time monitoring technologies has enhanced precision and safety, allowing for consistent therapeutic outcomes with reduced side effects. Furthermore, modern anesthesia protocols, including the use of short-acting agents like methohexital and muscle relaxants such as succinylcholine, contribute to smoother procedures with rapid recovery times. Data management systems now allow institutions to track treatment progress, optimize protocols, and integrate findings into patient records. These innovations are demystifying the procedure and reshaping public and professional perceptions of ECT. As a result, mental health practitioners and advocacy groups are increasingly advocating for ECT as a valid option in the continuum of care, reducing stigma and promoting earlier intervention in severe psychiatric cases.

Why Do Regional Healthcare Policies and Cultural Perceptions Impact the Utilization of ECT?

The adoption and practice of electroconvulsive therapy vary widely across regions, largely influenced by healthcare infrastructure, regulatory policies, cultural attitudes, and mental health awareness levels. In high-income countries such as the United States, Canada, the United Kingdom, and Australia, ECT is commonly offered in both inpatient psychiatric units and outpatient mental health clinics, supported by established guidelines from professional bodies like the American Psychiatric Association (APA) and the Royal College of Psychiatrists. Insurance coverage, physician training, and the presence of specialized facilities make access to ECT more consistent in these regions. In contrast, low- and middle-income countries often face barriers such as limited psychiatric resources, lack of trained personnel, and outdated equipment, which restrict the availability and quality of ECT services. Moreover, cultural stigmas associated with mental illness and fear of ECT as portrayed in media continue to hinder acceptance and patient consent. Some countries impose legal restrictions on its use for minors or require judicial approval, which can delay or prevent treatment. Ethical debates around consent and cognitive side effects also shape policy and practice. However, global mental health initiatives and WHO-backed programs are increasingly recognizing the importance of ECT in emergency psychiatry and are working to standardize protocols, train clinicians, and expand access in underserved regions. These efforts are crucial in bridging the treatment gap for severe mental illnesses across diverse populations.

What Are the Key Drivers Fueling Growth in the Global Electroconvulsive Therapy Market?

The growth in the global electroconvulsive therapy market is being fueled by rising mental health disorder prevalence, expanding treatment-resistant patient populations, and increasing institutional recognition of ECT as a safe and effective intervention. Major depressive disorder, which affects hundreds of millions globally, is the primary condition for which ECT is indicated, and the proportion of patients unresponsive to medications is steadily increasing. The growing awareness among clinicians and families of ECT's rapid effectiveness in life-threatening psychiatric conditions-such as severe depression with suicidal ideation or psychotic features-is driving its uptake in both public and private healthcare systems. Advances in healthcare infrastructure, particularly in tertiary psychiatric care facilities, have also played a role, enabling wider procedural availability and improved patient outcomes. Furthermore, aging populations in many countries are associated with increased incidence of late-life depression and dementia-related psychiatric symptoms, where ECT is often preferred due to its relatively favorable risk-benefit profile compared to polypharmacy. Regulatory support and growing insurance reimbursement coverage are reducing financial barriers for patients, while the inclusion of ECT in national mental health strategies underscores its clinical importance. As global demand for effective mental health interventions intensifies, ECT is poised to grow as a vital therapeutic modality-benefiting from modernization, evidence-based advocacy, and the urgent need to address the global mental health crisis.

SCOPE OF STUDY:

The report analyzes the Electroconvulsive Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Unilateral Electroconvulsive Therapy, Bilateral Electroconvulsive Therapy); Application (Major Depressive Disorder, Bipolar Disorder, Schizophrenia, Other Applications); End-User (Hospitals & Clinics, Ambulatory Surgery Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â